IMAX (IMAX) CEO trades 25,024 shares in 10b5-1 option exercises
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IMAX CORP Chief Executive Officer Richard L. Gelfond exercised stock options and sold the resulting common shares in pre-planned transactions. He converted a total of 25,024 stock options into common shares at an exercise price of $31.40 per share and sold the same 25,024 shares in open-market trades at prices of $40.0034 and $40.2621 per share.
These option exercises were made under a Rule 10b5-1 Plan dated December 9, 2025 and relate to options granted in 2016 that are set to expire on June 7, 2026. Following the transactions, Mr. Gelfond directly holds 765,002 common shares, with remaining outstanding option, restricted share unit and common share balances of 1,672,451, 231,562 and 765,002, respectively.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 25,024 shares ($1,004,405)
Net Sell
7 txns
Insider
GELFOND RICHARD L
Role
Chief Executive Officer
Sold
25,024 shs ($1.00M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | stock options (to buy) | 12,987 | $31.40 | $408K |
| Conversion | common shares | 12,987 | $31.40 | $408K |
| Sale | common shares | 12,987 | $40.2621 | $523K |
| Conversion | stock options (to buy) | 12,037 | $31.40 | $378K |
| Conversion | common shares | 12,037 | $31.40 | $378K |
| Sale | common shares | 12,037 | $40.0034 | $482K |
| holding | common shares (opening balance) | -- | -- | -- |
Holdings After Transaction:
stock options (to buy) — 1,672,451 shares (Direct);
common shares — 777,989 shares (Direct);
common shares (opening balance) — 765,002 shares (Direct)
Footnotes (1)
- Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. These options were issued in 2016 and are set to expire on June 7, 2026. The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,672,451, 231,562 and 765,002, respectively.
Key Figures
Options exercised: 25,024 shares
Exercise price: $31.40/share
Sale prices: $40.0034 and $40.2621/share
+3 more
6 metrics
Options exercised
25,024 shares
Total stock options converted to common shares on April 2 and 6, 2026
Exercise price
$31.40/share
Conversion or exercise price for stock options issued in 2016
Sale prices
$40.0034 and $40.2621/share
Open-market sales of common shares on April 2 and 6, 2026
Post-transaction common shares
765,002 shares
Direct common share holdings following reported transactions
Remaining stock options
1,672,451 options
Aggregate remaining outstanding option balance after these exercises
Remaining RSUs
231,562 units
Aggregate remaining restricted share unit balance after these transactions
Key Terms
Rule 10b5-1 Plan, stock options, restricted share unit, open-market sale, +1 more
5 terms
Rule 10b5-1 Plan financial
"conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
stock options financial
"Represents the conversion upon exercise of stock options into common shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"Conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What did IMAX (IMAX) CEO Richard Gelfond report in this Form 4?
IMAX CEO Richard Gelfond reported exercising stock options and selling the resulting common shares. He converted 25,024 options at $31.40 per share and sold the same number of shares in open-market transactions at prices just above $40 per share.
At what price did the IMAX CEO exercise his stock options?
The IMAX CEO exercised his stock options at a conversion or exercise price of $31.40 per share. These options were originally issued in 2016, became exercisable later that year, and are scheduled to expire on June 7, 2026 if not exercised.
Were the IMAX CEO’s transactions made under a Rule 10b5-1 trading plan?
Yes. A footnote explains that the option exercises and resulting share conversions were carried out pursuant to a Rule 10b5-1 Plan dated December 9, 2025. Such pre-arranged plans automate trading and can make the timing less indicative of discretionary decisions.
What happens to the IMAX stock options if not exercised by the CEO?
The footnotes state that the relevant IMAX stock options were issued in 2016 and are set to expire on June 7, 2026. If options are not exercised by their expiration date, they lapse and no longer give the right to acquire common shares.